1. Bosch, F.X.; Lorincz, A.; Munoz, N.; Meijer, C.J.; Shah, K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 2002, 55 (4), 244265.

2. Munoz, N.; Bosch, F.X.; de Sanjose, S.; Herrero, R.; Castellsague, X.; Shah, K.V.; Snijders, P.J.; Meijer, C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003, 348 (6), 518-527.

3. Pfister, H. Chapter 8: Human papillomavirus and skin cancer. J. Natl. Cancer Inst. Monographs 2003, 31, 5256.

4. Clavel, C.; Masure, M.; Putaud, I.; Thomas, K.; Bory, J.P.;

Gabriel, R.; Quereux, C.; Birembaut, P. Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions. J. Clin. Pathol. 1998, 51 (10), 737740.

5. Castle, P.E.; Schiffman, M.; Burk, R.D.; Wacholder, S.; Hildesheim, A.; Herrero, R.; Bratti, M.C.; Sherman, M.E.; Lorincz, A. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol. Biomark. Prev. 2002, 11 (11), 1394-1399.

6. van den Brule, A.J.; Pol, R.; Fransen-Daalmeijer, N.; Schouls, L.M.; Meijer, C.J.; Snijders, P.J. GP5 + /6 + PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papilloma-virus genotypes. J. Clin. Microbiol. 2002, 40 (3), 779787.

7. Gravitt, P.E.; Peyton, C.L.; Apple, R.J.; Wheeler, C.M. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J. Clin. Microbiol. 1998, 36 (10), 3020-3027.

8. Tieben, L.M.; ter Schegget, J.; Minnaar, R.P.; Bouwes Bavinck, J.N.; Berkhout, R.J.; Vermeer, B.J.; Jebbink, M.F.; Smits, H.L. Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J. Virol. Methods 1993, 42 (2-3), 265-279.

9. Gregoire, L.; Arella, M.; Campione-Piccardo, J.; Lancaster, W.D. Amplification of human papillomavirus DNA sequences by using conserved primers. J. Clin. Microbiol. 1989, 27 (12), 2660-2665.

10. Kleter, B.; van Doorn, L.J.; Schrauwen, L.; Molijn, A.; Sastrowijoto, S.; ter Schegget, J.; Lindeman, J.; ter Harmsel, B.; Burger, M.; Quint, W. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 1999, 37 (8), 2508-2517.

11. Cho, N.H.; An, H.J.; Jeong, J.K.; Kang, S.; Kim, J.W.; Kim, Y.T.; Park, T.K. Genotyping of 22 human papillomavirus types by DNA chip in Korean women: Comparison with cytologic diagnosis. Am. J. Obstet. Gynecol. 2003, 188 (1), 56 -62.

12. Jacobs, M.V.; Snijders, P.J.; van den Brule, A.J.; Helmer-horst, T.J.; Meijer, C.J.; Walboomers, J.M. A general primer GP5+/GP6( + )-mediated PCR-enzyme immunoas-say method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J. Clin. Microbiol. 1997, 35 (3), 791-795.

13. Forslund, O.; Antonsson, A.; Nordin, P.; Stenquist, B.; Hansson, B.G. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J. Gen. Virol. 1999, 80 (Pt 9), 2437-2443.

14. Shamanin, V.; Glover, M.; Rausch, C.; Proby, C.; Leigh, I.M.; zur, H.H.; de Villiers, E.M. Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res. 1994, 54 (17), 4610-4613.

15. Lungu, O.; Wright, T.C., Jr.; Silverstein, S. Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP 19. analysis. Mol. Cell. Probes 1992, 6 (2), 145-152.

16. Szuhai, K.; Sandhaus, E.; Kolkman-Uljee, S.M.; Lemaitre, M.; Truffert, J.-C.; Dirks, R.W.; Tanke, H.J.; Fleuren, G.J.; Schuuring, E.; Raap, A.K. A novel strategy for HPV detection and genotyping with SybrGreen and molecular beacon PCR. Am. J. Pathol. 2001, 159, 1651-1660. 20.

17. Walboomers, J.M.; Jacobs, M.V.; Manos, M.M.; Bosch, F.X.; Kummer, J.A.; Shah, K.V.; Snijders, P.J.; Peto, J.; Meijer, C.J.; Munoz, N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189 (1), 12-19.

18. Snijders, P.J.; van den Brule, A.J.; Meijer, C.J. The clinical 21. relevance of human papillomavirus testing: Relationship between analytical and clinical sensitivity. J. Pathol. 2003, 201 (1), 1-6.

Nobbenhuis, M.A.; Walboomers, J.M.; Helmerhorst, T.J.; Rozendaal, L.; Remmink, A.J.; Risse, E.K.; van der Linden, H.C.; Voorhorst, F.J.; Kenemans, P.; Meijer, C.J. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: A prospective study. Lancet 1999, 354 (9172), 20-25. Nobbenhuis, M.A.; Meijer, C.J.; van den Brule, A.J.; Rozendaal, L.; Voorhorst, F.J.; Risse, E.K.; Verheijen, R.H.; Helmerhorst, T.J. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br. J. Cancer 2001, 84 (6), 796-801.

Galloway, D.A. Papillomavirus vaccines in clinical trials. Lancet, Infect. Dis. 2003, 3 (8), 469-475.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment